⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2746197 | 0.83 | TDP1 (0.31) | — | |
| SCHEMBL4409941 | 0.78 | — | — | |
| Hydrogen Sulfide SCHEMBL28118619 | 0.76 | — | — | |
| SCHEMBL11214563 | 0.72 | MCL1 (0.33) | — | |
| SCHEMBL1934300 | 0.69 | — | — | |
| SCHEMBL671159 | 0.69 | — | — | |
| SCHEMBL6227300 | 0.69 | DPP4 (0.50) | — | |
| SCHEMBL6255006 | 0.69 | MCL1 (0.37) | — | |
| SCHEMBL170153 | 0.67 | — | — | |
| SCHEMBL1937504 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2379537-B9 | Isoxazoline derivatives and their use as pesticide | NOVARTIS AG (CH) | 2017-07-12 | — | — | EP | claimed |
| US-9044389-B2 | Isoxazoline derivatives as pesticides | NOVARTIS TIERGESUNDHEIT AG (CH) | 2015-06-02 | — | — | US | claimed |
| US-20140120147-A1 | ISOXAZOLINE DERIVATIVES AS PESTICIDES | NOVARTIS AG (CH) | 2014-05-01 | — | — | US | claimed |
| US-8653116-B2 | Isoxazoline derivatives as pesticides | NOVARTIS AG (CH) | 2014-02-18 | — | — | US | claimed |
| US-20130131053-A1 | ISOXAZOLINE DERIVATIVES AS PESTICIDES | NOVARTIS TIERGESUNDHEIT AG (CH) | 2013-05-23 | — | — | US | claimed |
| EP-2379537-B1 | Isoxazoline derivatives and their use as pesticide | NOVARTIS AG (CH) | 2012-10-31 | — | — | EP | claimed |
| US-20140343085-A1 | USE OF ARYL DERIVATIVES FOR CONTROLLING ECTOPARASITES | NOVARTIS AG (CH) | 2014-11-20 | — | — | US | disclosed |
| EP-2785341-A1 | ARYL DERIVATIVES FOR CONTROLLING ECTOPARASITES | Novartis AG (CH) | 2014-10-08 | — | — | EP | disclosed |
| WO-2014053555-A1 | VETERINARY DRUG SYSTEM | NOVARTIS AG (CH) | 2014-04-10 | — | — | WO | disclosed |
| WO-2013079407-A1 | ARYL DERIVATIVES FOR CONTROLLING ECTOPARASITES | NOVARTIS AG (CH) | 2013-06-06 | — | — | WO | disclosed |
| EP-1569954-A1 | CYANOMETHYL DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS | AXYS PHARMACEUTICALS, INC. (US) | 2005-09-07 | — | — | EP | disclosed |
| WO-2004052921-A1 | CYANOMETHYL DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS | AXYS PHARMACEUTICALS, INC. (US) | 2004-06-24 | — | — | WO | disclosed |